Comparing the Efficacy of Two Neurofeedback Protocols for Generalized Anxiety Disorder

April 11, 2024 updated by: Abbas Masjedi Arani, Shahid Beheshti University of Medical Sciences

Comparing the Efficacy of Two Neurofeedback Protocols for Generalized Anxiety Disorder: Sensory Motor Rhythm and Alpha-Theta

Generalized anxiety disorder (GAD) is one of the most prevalent mental disorders in adults, marked by excessive and uncontrollable worry about various events or activities. It is accompanied by symptoms such as restlessness, irritability, fatigue, difficulty concentrating, problems with sleep, and somatic symptoms.

In addition, a critical and up-to-date comparison of different treatments for GAD is crucial due to their high costs and unsatisfactory outcomes. EEG neurofeedback training has not reached the same level of evidence as more extensively validated non-pharmacological treatments, such as cognitive behavioral therapy.This study aimed to compare the efficacy of two protocols: one targeting alpha-theta amplitude increase and the other concentrating on SMR.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Normal hearing and vision,
  • had never undergone neurofeedback sessions,
  • diagnosed as GAD by a psychiatrist,
  • no history of neurological disorders
  • undergoing other therapies

Exclusion Criteria:

  • started other treatments during the study
  • missed more than one session

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Alph-Theta
15 sessions of alpha (8-12Hz) and theta (4-8Hz) push on Pz based on 10-20 international system
neurofeedback training over five weeks, comprising 15 sessions. Each neurofeedback training session lasted 30 minutes.
Experimental: Sensory Motor Rhythm
15 sessions of sensory-motor rhythm (12-15Hz) push on Cz based on 10-20 international system
neurofeedback training over five weeks, comprising 15 sessions. Each neurofeedback training session lasted 30 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Beck Anxiety Inventory
Time Frame: Pre-test, after 5 weeks and two month follow up
higher scores mean higher depression
Pre-test, after 5 weeks and two month follow up
The Perceived Stress Questionnaire
Time Frame: Pre-test, after 5 weeks and two month follow up
higher scores mean higher stress
Pre-test, after 5 weeks and two month follow up
Spielberger's state-trait anxiety test
Time Frame: Pre-test, after 5 weeks and two month follow up
higher scores mean higher anxiety
Pre-test, after 5 weeks and two month follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2022

Primary Completion (Actual)

July 1, 2023

Study Completion (Actual)

July 1, 2023

Study Registration Dates

First Submitted

April 3, 2024

First Submitted That Met QC Criteria

April 11, 2024

First Posted (Actual)

April 12, 2024

Study Record Updates

Last Update Posted (Actual)

April 12, 2024

Last Update Submitted That Met QC Criteria

April 11, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IR.SBMU.MSP.REC. 1401. 161

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Generalized Anxiety Disorder

Clinical Trials on EEG Neurofeedback

Subscribe